Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001179110-10-016344

Options or other derivatives

  • CFO and Treasurer acquired 425,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BROOKS JOEL · CFO and Treasurer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2010-11-17 Grant or award : show line 1 in the form Common Stock Option +425,000 $0.26 2020-11-17 425,000 882,500 D
Loading xslF345X03/edgar.xml…